Standard Nuclear, the Oak Ridge based, reactor agnostic TRISO fuel maker, launched its IPO roadshow on July 7, 2026, marketing 18.25 million Class A shares at $18 to $21 to raise up to $383 million at roughly a $3.5 billion valuation, with NYSE trading under STDN expected around July 16. The company bills itself as the only US independent manufacturer with industrial scale TRISO capability, yet reported just $593,802 of revenue and a $7.7 million net loss for the March quarter, so the pricing rests almost entirely on the policy and demand narrative: the DOE Reactor Pilot Program targeting criticality by July 4, 2026, a February DOE pilot selecting Oklo, Terrestrial, TRISO-X, and Valar for advanced fuel lines, and AI data center power demand pulling capital into advanced nuclear. Since STDN is not yet tradable, this briefing maps the investable adjacencies: Oklo (STDN MOU partner and pilot reactor developer), Centrus (HALEU enrichment feeding TRISO fabricators, including an LOI to supply up to five Oklo Aurora plants from 2029), BWX Technologies (already fabricating TRISO that powered the Antares Mark-0 to first criticality, with $861 million Q1 revenue and an $8.7 billion backlog), and X-Energy (TRISO-X fuel plant plus the Xe-100). All are pre-revenue or early cycle on the advanced side; X-Energy trades below its April IPO price. Risk forward view: real catalysts, extreme valuation dispersion, binary regulatory outcomes. Not financial advice.
Oklo signed an MOU with Standard Nuclear on fuel recycling and advanced fuel collaboration, and an LOI with Centrus for HALEU to power up to five Aurora powerhouses supporting a planned 1.2 GW Ohio campus. Execution to first commercial revenue is the whole story.
Q1 2026 net loss of $33.1 million with zero revenue; 2026 guidance of $80-$100 million operating cash burn and $350-$450 million capex. Shares at $46.99 are down about 3.8% today after a steep 2026 pullback versus the IWM's 42% 12-month gain.
A pre-revenue reactor developer where a single criticality date can reprice the stock in either direction.
The Oklo LOI for up to five Aurora plants with deliveries from 2029, plus the earlier TRISO-X fabrication contract with X-Energy, position Centrus's Piketon American Centrifuge Plant as the upstream toll booth for the entire advanced reactor buildout.
LEU trades at $168.23, down 1.6% today, after a multi-year rerating on enrichment scarcity. Downstream demand signals include Oklo's planned 1.2 GW Ohio campus and DOE's four-company fuel line pilot announced in February 2026.
The picks-and-shovels enrichment play sitting upstream of every TRISO fabricator, priced accordingly.
Unlike pre-revenue peers, BWXT pairs advanced fuel optionality (Project Pele, additive TRISO manufacturing, CVI furnace milestones) with a profitable defense nuclear core. It is the incumbent Standard Nuclear must displace to own the TRISO market.
Q1 2026 revenue of $861.1 million, roughly 23% gross margin, and an $8.7 billion backlog. Shares at $183.18, down 1.5% today, offer the lowest execution risk in this cohort.
The proven, profitable TRISO incumbent, with growth priced more like a defense prime than a nuclear startup.
X-Energy pairs the Xe-100 high-temperature gas reactor with its own TRISO-X fuel fabrication facility, whose preliminary design was completed with Centrus. TRISO-X's selection in DOE's February 2026 fuel line pilot is a real catalyst, but commercialization remains years out.
XE trades at $15.98, roughly flat today and below its April 2026 IPO level. The sector-wide pullback reflects investors waiting on tangible SMR deployment progress rather than announcements.
A vertically integrated TRISO-plus-reactor bet trading at a discount to its own IPO enthusiasm.
Standard Nuclear markets itself as the only independent US company with industrial-scale TRISO manufacturing, with an Oklo MOU and space and defense radioisotope lines. The valuation embeds near-perfect execution of a market that barely exists yet.
Deal: 18.25 million shares at $18 to $21, up to $383 million raised, about $3.5 billion market value; Q1 revenue of $593,802 against a $7.7 million net loss, and a $838 million private valuation as recently as January 2026, a 4x markup in six months.
The purest TRISO story in the market and also its most aggressively priced, worth watching from the sidelines through lockup.
This briefing is one run. Generate live macro intelligence across any sector, on demand, free.
🚀 Enter Just Signal